Answers are grounded in this paper and cite their sources.
In conclusion, the medicines for chronic obstructive pulmonary disease cause many serious adverse drug reactions, most of them were unexpected, lacking in the short product characteristics. Appropriate reporting of adverse drug reactions is necessary to decrease the risk of patients and healthcare system.
No takes yet. Share an insight, caveat, or question.
Petrova et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: